Transcend Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Sell |
1,744
-1,522
| -47% | -$677K | 0.06% | 266 |
|
|
2025
Q1 | $1.58M | Buy |
3,266
+10
| +0.3% | +$4.85K | 0.11% | 188 |
|
|
2024
Q4 | $1.31M | Buy |
3,256
+875
| +37% | +$352K | 0.09% | 210 |
|
|
2024
Q3 | $1.11M | Buy |
2,381
+785
| +49% | +$365K | 0.07% | 248 |
|
|
2024
Q2 | $748K | Buy |
+1,596
| New | +$748K | 0.05% | 298 |
|
|
2023
Q1 | – | Sell |
-816
| Closed | -$236K | – | 524 |
|
|
2022
Q4 | $236K | Buy |
+816
| New | +$236K | 0.03% | 415 |
|